6-minute walk test

Weekly treatment with eteplirsen resulted in a 69.4-meter benefit on the 6-minute walk compared to placebo/delayed treatment; study extends earlier results showing eteplirsen caused dystrophin production

posted on July 24, 2012 - 10:55am
Editor's note (July 24, 2012): For a more in-depth discussion of the exon-skipping trial results, see A Closer Look: Extended Eteplirsen Treatment Benefits Walking in DMD.

New content is being added every day. Please check back again.